recent
zoonot
diseas
consist
occur
differ
countri
worldwid
caus
seriou
threat
mani
countri
human
global
respect
prevent
educ
variou
zoonot
diseas
becom
major
issu
toxoplasmosi
parasit
diseas
induc
infect
toxoplasma
gondii
mani
countri
worldwid
zoonot
parasitosi
caus
seriou
diseas
chronic
infect
variou
site
human
bodi
age
group
includ
adult
young
children
well
pregnant
women
particular
toxoplasmosi
zoonot
diseas
infect
human
cat
mani
peopl
cat
pet
particularli
pregnant
women
need
take
caution
regard
biolog
aspect
gondii
intracellular
organel
golgi
endoplasm
reticulum
mitochondrion
also
uniqu
subcellular
organel
conoid
apicoplast
surfac
antigen
sag
dens
granul
protein
gra
rhoptri
micronem
gondii
inner
membran
complex
imc
involv
plasma
membran
consist
uniqu
doubl
membran
structur
combin
cytoskelet
network
imc
act
major
factor
prolifer
growth
surviv
gondii
well
motil
cell
divis
report
includ
differ
subprotein
imc
subcompart
protein
protein
kinas
gondii
known
play
key
role
modul
motil
invas
replic
egress
surviv
within
host
report
gondii
divid
uniqu
form
cell
divis
endodyogeni
chromosom
passeng
complex
essenti
organ
function
mitot
spindl
furthermor
gondii
form
parasitophor
vacuol
membran
pvm
invas
host
cell
also
prolifer
grow
pvm
decad
sever
compound
mani
research
group
develop
drug
treat
toxoplasmosi
use
use
clinic
howev
exist
drug
wide
vulner
drugresist
clinic
global
overcom
pharmacolog
barrier
challeng
effort
treat
infecti
diseas
attempt
variou
field
report
variou
extractscompound
deriv
medicin
plant
new
synthet
compound
antit
gondii
effect
vitro
preclin
stage
recent
variou
compound
deriv
plant
show
lead
role
abil
sourc
special
metabolit
medic
effect
well
pharmacolog
activ
addit
report
variou
extractscompound
deriv
plant
synthet
compound
could
use
medic
field
use
resourc
treat
acut
chronic
infecti
diseas
caus
schistosomiasi
leishmania
malaria
tuberculosi
well
viral
diseas
includ
middl
east
respiratori
syndrom
mer
zika
fever
avian
influenza
howev
effect
nextgener
drug
treat
toxoplasmosi
yet
develop
difficulti
drug
develop
zoonosi
still
caus
public
health
crisi
global
context
variou
studi
develop
discoveri
effect
drug
novel
candid
parasit
zoonosi
urgent
requir
regard
ursol
acid
bioactiv
compound
deriv
medicin
plant
also
known
select
bioactiv
properti
antiinflammatori
anticanc
effect
also
effect
induc
variou
activ
includ
antimicrobi
antiparasit
effect
recent
although
studi
compound
regard
antit
gondii
activ
report
global
mechan
action
ursol
acid
inhibitori
effect
gondii
immunomodulatori
activ
report
yet
perspect
studi
perform
evalu
mechan
action
immunomodulatori
activ
ursol
acid
term
antit
gondii
effect
activ
confirm
potenti
potent
candid
drug
develop
novel
antitoxoplasmosi
agent
gondii
specif
network
structur
system
includ
variou
intracellular
organel
mitochondrion
apicoplast
dens
granul
rhoptri
figur
induc
seriou
zoonot
diseas
toxoplasmosi
particularli
human
caus
infect
variou
vertebr
evalu
mechan
action
ursol
acid
gondii
measur
inhibitori
effect
ursol
acid
ua
surviv
gondii
normal
lung
cell
infect
gondii
mtt
assay
describ
previous
show
signific
result
reproduc
gondii
treat
ua
h
viabil
effect
inhibit
parasit
surviv
rate
measur
less
ua
strongli
decreas
viabil
gondii
compar
sulfadiazin
sf
demonstr
ua
caus
antit
gondii
effect
activ
gondi
data
shown
particular
lung
cell
infect
gondii
markedli
inhibit
dosedepend
manner
treatment
ursol
acid
compar
untreat
infect
cell
gondiiinfect
cell
treat
sf
figur
furthermor
clearli
shown
signific
differ
untreat
gondiigroup
experiment
group
aspect
demonstr
ua
effect
induc
select
antiparasit
effectact
compar
sftreat
group
untreat
group
direct
inhibitori
effect
viabil
gondii
show
ua
potenti
util
antit
gondii
candid
agent
andor
synerg
compound
exist
drug
develop
novel
antitoxoplasmosi
agent
therefor
result
indic
ua
strongli
inhibit
block
surviv
gondii
effect
induc
antit
gondii
activ
select
inhibitori
activ
andor
action
viabil
gondii
gondii
caus
uniqu
antiapoptot
featur
parasit
surviv
cycl
stage
inactiv
apoptot
protein
parasit
lifecycl
host
cell
infect
show
critic
role
prolifer
surviv
gondii
particular
pvm
function
critic
indic
prolifer
stage
gondii
activ
timedepend
manner
cell
invas
gondii
caus
final
prolifer
growth
gondii
aspect
investig
inhibitori
action
ua
subcellular
organel
rhoptri
micronem
inner
membran
complex
form
intracellular
metabol
network
well
homeostasi
gondii
shown
figur
gondii
treat
differ
concentr
ua
sf
respect
intracellular
organel
rhoptri
protein
rop
micronem
protein
mic
inner
membran
complex
subcompart
protein
imc
gondii
markedli
decreas
dosedepend
manner
chang
clearli
observ
electrophoresi
particular
known
rhoptri
play
critic
factor
gondii
enter
host
cell
invas
stage
aspect
result
show
clearli
ua
direct
inhibitori
effect
surviv
gondii
also
induc
antit
gondii
effect
strongli
block
inhibit
homeostasi
network
structur
intracellular
organel
gondii
therefor
result
demonstr
substanti
evid
ua
consist
caus
antit
gondii
activityact
effect
inhibit
intracellular
organel
gondii
evalu
effect
ro
product
induc
ursol
acid
immun
cell
infect
gondii
product
ro
measur
dosedepend
manner
gondiiinfect
cocultur
immun
cell
incub
variou
concentr
ua
sf
h
respect
particular
product
ro
increas
gondiiinfect
group
treat
ua
compar
gondiiinfect
group
howev
ua
ro
activ
gradual
indic
lower
concentr
uatreat
group
figur
chang
ro
activ
show
ua
act
modul
consist
inhibit
prolifer
growth
gondii
promot
product
ro
immun
cell
parasit
infect
even
though
sftreat
group
significantli
increas
ro
product
compar
gondiiinfect
group
low
rosproduct
rate
compar
uatreat
group
furthermor
rate
product
strongli
increas
gondiiinfect
group
treat
ua
compar
normal
gondiiinfect
group
rang
ua
rate
product
low
concentr
compar
uatreat
group
figur
howev
activ
ro
induc
ua
significantli
increas
normal
infect
group
interestingli
activ
ro
gondiiinfect
cell
treat
sf
lower
gondiiinfect
group
treat
ua
activ
ro
significantli
increas
gondiiinfect
group
treat
ua
sf
respect
wherea
activ
gradual
reduc
high
concentr
result
show
ua
consist
induc
product
ro
interact
immun
cell
gondiiinfect
immun
cell
may
also
use
synerg
compound
immunomodul
parasit
infect
gondii
prolifer
rapidli
host
cell
parasit
interact
signal
surviv
cell
invas
final
induc
destruct
host
cell
evalu
synerg
effect
activ
cytokin
caus
ursol
acid
cocultur
immun
cell
macrophag
cell
b
cell
basophil
cell
infect
gondii
product
cytokin
granulocyt
macrophag
coloni
stimul
factor
gmcsf
transform
growth
factor
beta
tumor
necrosi
factor
alpha
gondiiinfect
immun
cell
notabl
chang
concentrationdepend
manner
cell
incub
differ
concentr
ua
chang
measur
elisa
reader
particular
product
gmcsf
effect
increas
gondiiinfect
cell
treat
ua
compar
gondiiinfect
cell
chang
show
ua
acceler
product
releas
gmcsf
stimul
macrophag
b
cell
basophil
cell
figur
moreov
product
chang
sftreat
group
product
gmcsf
gradual
decreas
furthermor
express
markedli
reduc
gondiiinfect
cell
treat
ua
wherea
gondiiinfect
cell
treat
sf
caus
product
compar
group
figur
interestingli
gondiiinfect
cell
treat
sf
significantli
produc
express
compar
infect
group
show
sf
involv
immun
respons
express
immun
cell
furthermor
product
decreas
gondiiinfect
cell
treat
ua
result
show
ua
reduc
express
immun
cell
directli
inhibit
gondii
result
demonstr
ua
promot
defens
parasit
infect
effect
induc
product
gmcsf
immun
cell
cell
infect
gondii
also
inhibit
overexpress
inflammatori
cytokin
reduc
express
caus
infect
evalu
activ
interact
variou
cytokin
induc
ursol
acid
cocultur
immun
cell
macrophag
cell
b
cell
basophil
cell
infect
gondii
chang
cytokin
interleukin
il
gondiiinfect
immun
cell
measur
dosedepend
manner
cell
incub
differ
concentr
ua
chang
evalu
elisa
reader
particular
product
reduc
group
treat
ua
compar
infect
group
express
significantli
increas
gondiiinfect
cell
treat
ua
figur
figur
chang
demonstr
ua
promot
product
express
consist
stimul
immun
cell
well
inhibit
express
induc
gondii
infect
interestingli
product
gondiiinfect
cell
treat
sf
significantli
increas
express
gradual
decreas
compar
infect
group
howev
signific
chang
product
gondiiinfect
cell
treat
sf
particular
signific
differ
cytokin
clearli
measur
gondiiinfect
group
uatreat
group
chang
cytokin
confirm
group
furthermor
result
show
cocultur
system
immun
cell
use
util
cocultur
method
measur
variou
cytokin
effect
altern
vivo
experi
result
indic
ua
effect
induc
product
cytokin
immun
cell
increas
express
macrophag
b
cell
gondii
infect
also
suppress
strongli
reduc
express
inflammatori
cytokin
immun
cell
spite
constant
public
health
effort
worldwid
past
decad
infecti
diseas
malaria
influenza
cholera
yellow
fever
mer
sar
tuberculosi
consist
caus
crise
public
health
well
global
concern
due
pandem
potenti
seriou
infecti
pathogen
enhanc
adapt
environment
variat
infect
host
well
resist
exist
drug
viabil
evolv
timedepend
manner
aspect
global
nonprofit
organ
andor
profit
compani
bill
melinda
gate
foundat
well
variou
global
lead
pharmaceut
compani
continu
support
studi
block
treat
chronic
infecti
diseas
zika
aid
tuberculosi
well
acut
infecti
diseas
includ
influenza
malaria
cholera
yellow
fever
ebola
focus
develop
novel
drug
effect
vaccin
pathogen
furthermor
spite
variou
effort
develop
antiparasit
drug
zoonot
parasitosi
effect
novel
drug
antimalaria
drug
yet
develop
launch
mani
peopl
live
anim
cat
dog
particular
toxoplasmosi
zoonot
parasitosi
transmit
via
physic
contact
pet
companion
anim
includ
cat
dog
respect
aspect
care
focus
parasit
infecti
diseas
consist
caus
variou
infect
pathway
factor
among
variou
parasit
gondii
induc
seriou
symptom
cerebr
calcif
meningoenceph
brain
caus
fetal
infect
mother
pregnanc
zoonot
parasit
affect
human
anim
result
parasit
diseas
toxoplasmosi
furthermor
induc
seriou
complic
immunedefici
patient
hiv
patient
attenu
interact
immun
system
specif
respond
pathogen
host
gondii
inhibit
interact
cytokin
activ
immun
system
attenu
product
cytokin
host
cell
addit
known
gondii
block
parasit
inhibitori
system
inhibit
signal
pathway
cell
cycl
initi
apoptot
mediat
apoptot
stage
host
cell
invas
gondii
infect
induc
imbal
immun
respons
caus
chang
cytokin
host
result
immun
defici
break
homeostasi
interact
immun
system
host
moreov
gondii
induc
prolif
growth
cycl
gondii
rapidli
form
pvm
regul
cell
cycl
factor
surviv
host
cell
maintain
surviv
acceler
prolifer
gondii
host
subcellular
organel
granul
gondii
conoid
gra
sag
rhoptri
micronem
protein
inner
membran
complex
focus
upon
major
target
block
gondii
infect
use
major
recombin
protein
factor
protect
immun
includ
vaccin
reason
studi
evalu
antiparasit
effect
ua
inhibit
surviv
parasit
gondii
infect
gondiiinfect
cocultur
immun
system
also
confirm
mechan
action
respect
antit
gondii
effect
immunomodulatori
activ
present
studi
surviv
rate
gondii
markedli
inhibit
parasit
treat
ua
sf
compar
nontreat
gondii
group
express
subcellular
organel
granul
gondii
infect
cell
effect
decreas
gondiiinfect
group
treat
ua
compar
group
furthermor
product
ro
significantli
increas
gondiiinfect
group
treat
ua
compar
sftreat
infect
group
interestingli
although
ro
product
activ
gondiiinfect
cell
treat
ua
sf
rate
gradual
decreas
rang
high
concentr
compound
aspect
ro
product
activ
immun
defens
system
variou
pathogen
bacteria
virus
also
maintain
effect
chang
homeostasi
organ
promot
product
cytokin
induc
interact
immun
cell
cytokin
increas
infect
cell
gondii
infect
product
significantli
suppress
ua
treatment
particular
although
product
reduc
gondiiinfect
immun
cell
treat
ua
shown
ua
suppress
express
immun
cell
inhibit
surviv
gondii
addit
ua
effect
increas
product
antiinflammatori
cytokin
gondiiinfect
cell
also
activ
express
gmcsf
promot
develop
cell
product
induc
nk
cell
taken
togeth
result
studi
show
antiparasit
effect
ua
surviv
gondii
well
demonstr
mechan
action
caus
antit
gondii
effect
gondiiinfect
cocultur
cell
furthermor
result
indic
express
subcellular
organel
granul
gondii
specif
inhibit
block
concentrationdepend
manner
treatment
ua
studi
provid
evid
ua
decreas
inflammatori
cytokin
express
immun
cell
gondii
infect
also
effect
increas
product
antiinflammatori
mediat
gmcsf
includ
activ
ro
product
interestingli
confirm
studi
macrophag
immun
cell
directli
inhibit
rapidli
decreas
surviv
parasit
well
prolifer
gondii
bactericid
action
phagocytosi
macrophag
gondii
infect
may
result
differ
vitro
system
vivo
experi
includ
rat
mice
howev
parasit
may
elimin
bactericid
action
macrophag
immun
cell
infect
bodi
gondii
found
variou
bodi
site
patient
clinic
moreov
may
chang
maintain
parasit
type
indic
characterist
hibern
like
gondii
strain
type
ii
bodi
summari
result
studi
demonstr
ua
induc
antit
gondii
effectsact
effect
block
inhibit
surviv
gondii
also
antiparasit
activ
consist
inhibit
proliferationgrowth
gondii
strongli
inhibit
express
subcellular
organel
granul
gondii
rop
mic
imc
sub
gondiiinfect
cell
addit
result
show
clearli
ua
immunomodulatori
actionact
caus
chang
cytokin
immun
cell
decreas
inflammatori
cytokin
andor
activ
antiinflammatori
cytokin
includ
gmcsf
interact
ua
immun
cell
furthermor
result
indic
ua
induc
death
gondii
promot
product
ro
super
oxid
hydroxyl
radic
gondiiinfect
immun
cell
therefor
studi
indic
ua
use
effect
potent
candid
agent
synerg
compound
exist
drug
develop
novel
antit
gondii
drug
next
gener
toxoplasmosi
potenti
modulatori
substanc
immun
respons
parasit
parasiteinfect
immun
cell
moreov
ua
requir
studi
efficaci
safeti
toxoplasmosi
preclin
stage
vivo
anim
model
near
futur
rpmi
medium
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
phosphat
buffer
salin
pb
antibiot
trypsinedta
solut
purchas
invitrogen
corpor
usa
mtt
bromid
thiazolyl
blue
dimethyl
sulfoxid
dmso
trypan
blue
sulfadiazin
purchas
sigmaaldrich
chemic
co
ltd
st
loui
mo
usa
chemic
reagent
purchas
sigmaaldrich
chemic
co
ltd
st
loui
mo
usa
merck
chemic
co
ltd
darmstadt
germani
donginbio
co
ltd
seoul
south
korea
antitoxoplasmosi
drug
sulfadiazin
sf
dissolv
dmso
ursol
acid
ua
also
dissolv
dmso
concentr
mgml
accord
manufactur
instruct
sulfadiazin
use
standard
drug
evalu
whether
ursol
acid
antiparasit
effect
activ
gondii
compound
filter
use
membran
syring
filter
roshi
kaisha
ltd
tokyo
japan
use
store
deepfreez
use
macrophag
raw
cell
b
cell
basophil
cell
normal
lung
epitheli
cell
purchas
korean
cell
line
bank
seoul
nation
univers
american
type
cultur
collect
manassa
va
usa
cell
cultur
rpmi
medium
dmem
contain
mm
lglutamin
supplement
decompl
fetal
bovin
serum
fb
penicillin
unitsml
streptomycin
humidifi
atmospher
contain
air
gondii
rh
suspend
pb
inject
abdomin
caviti
balbcmous
five
day
inject
gondii
collect
periton
fluid
mous
kept
abdomin
caviti
mice
use
vitro
studi
host
cell
infect
tachyzoit
gondii
celltoparasit
ratio
inhibitori
effect
ursol
acid
gondii
confirm
directli
evalu
viabil
gondii
expos
ua
sf
mtt
assay
briefli
gondii
seed
plate
gondii
incub
differ
concentr
ua
sf
h
respect
normal
lung
cell
infect
gondii
cell
gondii
gondiiinfect
cell
treat
differ
concentr
ursol
acid
ua
sulfadiazin
sf
h
respect
viabil
evalu
mtt
assay
determin
whether
ua
antiparasit
activ
andor
effect
gondii
cell
divid
normal
experiment
group
surviv
rate
sr
gondii
calcul
follow
sr
oddrugtest
well
odblank
odcontrol
odblank
optic
densiti
od
measur
wavelength
nm
use
elisa
leader
inhibitori
effect
ursol
acid
viabil
gondii
evalu
measur
express
subcellular
organel
gondii
gondiiinfect
cell
expos
ua
sf
normal
lung
cell
seed
plate
cell
infect
gondii
cellsparasit
ratio
incub
differ
concentr
ua
sf
h
respect
total
rna
isol
gondii
strain
use
rneasi
mini
kit
qiagen
hilden
germani
total
rna
obtain
untreat
control
treat
group
follow
manufactur
recommend
procedur
total
rna
quantifi
eppendorf
biospectromet
eppendorf
seoul
korea
one
pair
primer
design
use
primer
version
ncbi
primerblast
accord
sequenc
select
specif
gene
ncbi
genbank
follow
gondii
mic
access
number
bp
rop
access
number
bp
imc
access
number
bp
access
number
bp
specif
gene
gondii
synthes
complementari
dna
cdna
onestep
rtpcr
kit
bioneer
daejeon
korea
cdna
analyz
electrophoresi
wv
agaros
gel
contain
ethidium
bromid
v
h
visual
ultraviolet
illumin
use
intern
standard
amount
express
cdna
present
sampl
group
divid
untreat
posit
group
gondiiinfect
group
experiment
group
ua
sftreat
group
effect
nitric
oxid
reactiv
oxygen
speci
ro
product
ursol
acid
confirm
measur
ro
product
gondiiinfect
cocultur
cell
macrophag
basophil
cell
expos
compound
cell
divid
normal
experiment
group
describ
briefli
cocultur
cell
seed
plate
cell
infect
gondii
cellsparasit
ratio
incub
differ
concentr
ua
sf
h
respect
ro
product
measur
control
treat
group
accord
manufactur
instruct
ro
product
kit
cell
biolab
inc
san
diego
ca
usa
respect
rate
ro
product
measur
use
elisa
micropl
leader
biotek
instrument
inc
winooski
vt
usa
effect
ursol
acid
regard
immunomodulatori
action
evalu
measur
express
cytokin
gondiiinfect
cocultur
immun
cell
macrophag
cell
b
cell
basophil
cell
expos
ua
sf
respect
cell
divid
normal
experiment
group
first
macrophag
basophil
cell
sequenti
seed
plate
humidifi
atmospher
contain
air
second
cell
b
cell
addit
seed
plate
h
name
cocultur
immun
cell
seed
plate
cell
final
infect
gondii
cellsparasit
ratio
h
incub
differ
concentr
ua
sf
h
respect
cytokin
gmcsf
respect
measur
normal
infect
treat
group
accord
manufactur
instruct
cytokin
elisa
kit
thermofish
scientif
san
diego
ca
usa
inflammatori
multicytokin
kit
qiagen
hilden
germani
untreat
gondiiinfect
cell
use
posit
group
result
express
mean
standard
deviat
sd
three
independ
experi
statist
analysi
data
perform
use
student
ttest
analysi
varianc
anova
valu
p
consid
statist
signific
